RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sun Pharmaceutical Industries Stock

Sun Pharmaceutical Industries ROA 2024

Sun Pharmaceutical Industries ROA

0.11

Ticker

SUNPHARMA.NS

ISIN

INE044A01036

In 2024, Sun Pharmaceutical Industries's return on assets (ROA) was 0.11, a 139.01% increase from the 0.05 ROA in the previous year.

Sun Pharmaceutical Industries Aktienanalyse

What does Sun Pharmaceutical Industries do?

Sun Pharmaceutical Industries Ltd is a leading company in the pharmaceutical industry, with its headquarters in Mumbai. The company was founded in 1983 by Dilip Shanghvi, a pharmacist who started with a capital of only 2000 rupees. The company's history began with the manufacturing of psychotropic drugs. However, Sun Pharma quickly expanded into other areas, including dermatology, cardiology, pain medicine, and oncology. Over the years, the company has acquired many companies and established itself in the pharmaceutical industry through mergers and acquisitions. It has a market presence in the USA, Europe, Japan, Australia, and Africa. Sun Pharmaceutical Industries Ltd's business model is based on the development and manufacturing of pharmaceuticals, generics, and biosimilars, as well as the provision of healthcare services. The company aims to provide innovative and affordable medicines to patients worldwide. Sun Pharma is divided into various segments, including generic drug manufacturing, specialty pharmaceuticals, and its own developed oncology platform. In the generic drug manufacturing, Sun Pharma is considered one of the world's largest suppliers, covering a wide range of therapeutic areas. One of its most well-known segments is the manufacturing of nerve blockers and painkillers. In fact, Sun Pharma was the first Indian corporation to receive approval for an opioid painkiller in the United States. Sun Pharmaceutical Industries Ltd offers a wide range of products, including: 1. Generics: The company is known for its cost-effective and high-quality generics, providing affordable treatment for a variety of diseases. 2. Biosimilars: Sun Pharma is also involved in the manufacturing of biosimilars, which has proven to be an important area. 3. Specialty pharmaceuticals: This segment includes a wide range of specialty pharmaceuticals, including medications for diabetes, asthma, and HIV treatment. 4. Oncology platform: Sun Pharma is focused on developing and marketing a wide range of oncology products, including cytostatics, immunotherapeutics, and cancer treatments. Sun Pharmaceutical Industries Ltd has a wide network of research and development facilities in India and around the world. The company has acquired numerous patents and licenses to develop and market innovative drugs. A particular capability lies in developing complex technologies and techniques to offer cost-effective therapies. In the past, Sun Pharma has faced some controversies, particularly related to the trading of opioids in the USA. However, the company has overcome these challenges and continues to focus on providing affordable and innovative medicines. In summary, Sun Pharmaceutical Industries Ltd is a leading company in the pharmaceutical industry. With a wide range of products and services and a global presence, it is a significant player in the global market. The company remains dedicated to developing innovative and affordable drugs to meet the needs of patients worldwide. Sun Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Sun Pharmaceutical Industries's Return on Assets (ROA)

Sun Pharmaceutical Industries's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Sun Pharmaceutical Industries's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Sun Pharmaceutical Industries's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Sun Pharmaceutical Industries’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Sun Pharmaceutical Industries stock

What is the Return on Assets (ROA) of Sun Pharmaceutical Industries this year?

The Return on Assets (ROA) of Sun Pharmaceutical Industries is 0.11 undefined this year.

What was the ROA of Sun Pharmaceutical Industries compared to the previous year?

The ROA of Sun Pharmaceutical Industries has increased by 139.01% compared to the previous year.

What consequences do high ROA have for investors of Sun Pharmaceutical Industries?

A high ROA is advantageous for investors of Sun Pharmaceutical Industries, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Sun Pharmaceutical Industries?

A low ROA can be unfavorable for investors of Sun Pharmaceutical Industries as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Sun Pharmaceutical Industries affect the company?

An increase in ROA of Sun Pharmaceutical Industries can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Sun Pharmaceutical Industries impact the company?

A reduction in the ROA of Sun Pharmaceutical Industries can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Sun Pharmaceutical Industries?

Some factors that can influence the ROA of Sun Pharmaceutical Industries include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Sun Pharmaceutical Industries important for investors?

The ROA of Sun Pharmaceutical Industries is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Sun Pharmaceutical Industries take to improve ROA?

To improve ROA, Sun Pharmaceutical Industries can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Sun Pharmaceutical Industries pay?

Over the past 12 months, Sun Pharmaceutical Industries paid a dividend of 13.5 INR . This corresponds to a dividend yield of about 0.75 %. For the coming 12 months, Sun Pharmaceutical Industries is expected to pay a dividend of 13.84 INR.

What is the dividend yield of Sun Pharmaceutical Industries?

The current dividend yield of Sun Pharmaceutical Industries is 0.75 %.

When does Sun Pharmaceutical Industries pay dividends?

Sun Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of March, August, March, August.

How secure is the dividend of Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries paid dividends every year for the past 23 years.

What is the dividend of Sun Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 13.84 INR are expected. This corresponds to a dividend yield of 0.76 %.

In which sector is Sun Pharmaceutical Industries located?

Sun Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sun Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sun Pharmaceutical Industries from 8/16/2024 amounting to 5 INR, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Sun Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 8/16/2024.

What was the dividend of Sun Pharmaceutical Industries in the year 2023?

In the year 2023, Sun Pharmaceutical Industries distributed 11.5 INR as dividends.

In which currency does Sun Pharmaceutical Industries pay out the dividend?

The dividends of Sun Pharmaceutical Industries are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sun Pharmaceutical Industries

Our stock analysis for Sun Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sun Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.